BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27811851)

  • 1. Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte-specific reporter line in zebrafish.
    Lin Q; Zhang Y; Zhou R; Zheng Y; Zhao L; Huang M; Zhang X; Leung AYH; Zhang W; Zhang Y
    Leukemia; 2017 May; 31(5):1206-1216. PubMed ID: 27811851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
    Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
    Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.
    Hirata S; Takayama N; Jono-Ohnishi R; Endo H; Nakamura S; Dohda T; Nishi M; Hamazaki Y; Ishii E; Kaneko S; Otsu M; Nakauchi H; Kunishima S; Eto K
    J Clin Invest; 2013 Sep; 123(9):3802-14. PubMed ID: 23908116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
    Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
    Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
    Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
    Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene.
    Ok Bozkaya İ; Yaralı N; Işık P; Ünsal Saç R; Tavil B; Tunç B
    Turk J Haematol; 2015 Jun; 32(2):172-4. PubMed ID: 26316487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
    Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia.
    Shah A; Kumar C; Shanmukhaiah C; Rajendran A; Mudaliar S; Idicula-Thomas S; Vundinti BR
    Ann Hematol; 2023 Oct; 102(10):2683-2693. PubMed ID: 37438490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.
    Savoia A; Dufour C; Locatelli F; Noris P; Ambaglio C; Rosti V; Zecca M; Ferrari S; di Bari F; Corcione A; Di Stazio M; Seri M; Balduini CL
    Haematologica; 2007 Sep; 92(9):1186-93. PubMed ID: 17666371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
    Germeshausen M; Ballmaier M; Welte K
    Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital amegakaryocytic thrombocytopenic purpura (CAMT).
    Ghauri RI; Naveed M; Mannan J
    J Coll Physicians Surg Pak; 2014 Apr; 24(4):285-7. PubMed ID: 24709246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].
    van den Oudenrijn S; Bruin M; de Haas M; von dem Borne AE
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):469-71. PubMed ID: 11913111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nonsense mutation in the MPL gene in congenital amegakaryocytic thrombocytopenia.
    Chung HS; Koh KN; Kim HJ; Kim HJ; Lee KO; Park CJ; Chi HS; Kim SH; Seo JJ; Im HJ
    Pediatr Blood Cancer; 2011 Feb; 56(2):304-6. PubMed ID: 21162090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-myeloablative conditioning is sufficient to achieve complete donor myeloid chimerism following matched sibling donor bone marrow transplant for myeloproliferative leukemia virus oncogene (
    Oved JH; Shah YB; Venella K; Paessler ME; Olson TS
    Front Pediatr; 2022; 10():903872. PubMed ID: 35967582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.
    Pecci A; Ragab I; Bozzi V; De Rocco D; Barozzi S; Giangregorio T; Ali H; Melazzini F; Sallam M; Alfano C; Pastore A; Balduini CL; Savoia A
    EMBO Mol Med; 2018 Jan; 10(1):63-75. PubMed ID: 29191945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Krukemeier S; Welte K
    Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents.
    Fox NE; Lim J; Chen R; Geddis AE
    Exp Hematol; 2010 May; 38(5):384-91. PubMed ID: 20188141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients.
    Germeshausen M; Ballmaier M
    Haematologica; 2021 Sep; 106(9):2439-2448. PubMed ID: 32703794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.